Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Asberg

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|August 2, 2013
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and CyclosporineA S Darwich, D Pade, K Rowland-Yeo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2010
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipientsA Asberg, A G Jardine, A A Bignamini, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarctionJ Ravkilde, M Hørder, W Gerhardt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomesA Humar, A Asberg, D Kumar, et al.
Ugeskrift for Laeger|November 28, 1994
[Troponin T in acute myocardial infarction. Diagnosis and prognosis in patients admitted for suspected acute myocardial infarction]J L Ravkilde, M Hørder, W Gerhardt, et al.
Clinical Pharmacology and Therapeutics|June 5, 2009
Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patientsI B Skottheim, K Stormark, H Christensen, et al.
Clinical Pharmacology and Therapeutics|January 31, 2013
Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjectsM Ulvestad, I B Skottheim, G S Jakobsen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2007
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipientsA Asberg, A Humar, H Rollag, et al.
Scandinavian Journal of Gastroenterology|October 9, 2001
Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 personsA Asberg, K Hveem, K Thorstensen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Analysis and clinical correlation of genetic variation in cytomegalovirusL F Lisboa, Y Tong, D Kumar, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
CPT: Pharmacometrics & Systems Pharmacology|August 2, 2013
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and CyclosporineA S Darwich, D Pade, K Rowland-Yeo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2010
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipientsA Asberg, A G Jardine, A A Bignamini, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarctionJ Ravkilde, M Hørder, W Gerhardt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomesA Humar, A Asberg, D Kumar, et al.
Ugeskrift for Laeger|November 28, 1994
[Troponin T in acute myocardial infarction. Diagnosis and prognosis in patients admitted for suspected acute myocardial infarction]J L Ravkilde, M Hørder, W Gerhardt, et al.
Clinical Pharmacology and Therapeutics|June 5, 2009
Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patientsI B Skottheim, K Stormark, H Christensen, et al.
Clinical Pharmacology and Therapeutics|January 31, 2013
Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjectsM Ulvestad, I B Skottheim, G S Jakobsen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2007
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipientsA Asberg, A Humar, H Rollag, et al.
Scandinavian Journal of Gastroenterology|October 9, 2001
Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 personsA Asberg, K Hveem, K Thorstensen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Analysis and clinical correlation of genetic variation in cytomegalovirusL F Lisboa, Y Tong, D Kumar, et al.
Pageof 7